Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 220/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Name : Chloroquinediphosphate
Shape : White powder
1. When this product is used in the treatment of malaria, there are few adverse reactions. Generally, the possible reactions of oral administration include dizziness, headache, dizziness, loss of appetite, nausea, vomiting, abdominal pain, diarrhea, pruritus, rash, tinnitus, irritability, etc.Most of the reactions are mild and disappear spontaneously after drug withdrawal.
2. A considerable part of this product can be accumulated in the tissue, long service can cause mild retinal edema and pigment aggregation, appear dark spots, affect vision, often irreversible.
3. Chloroquine can also damage hearing, pregnant women take a large number of children can cause congenital deafness, mental retardation.
4. Chloroquinol can cause sinus node inhibition, resulting in arrhythmia, shock, and in severe cases, A-S syndrome, which leads to death.
5. This product can also cause drug psychosis, leucopenia, purpura, rash, dermatitis, photosensitive dermatitis and even exfoliative dermatitis, psoriasis, hair whitening, hair depilation, neuromuscular pain, mild transient headache, etc.
6. Hemolysis, aplastic anemia, reversible granulocytosis and thrombocytopenia are rare .
Chloroquine phosphate, also known as N ',N '-diethyl-N4 -(7-chloro-4-quinolyl)-1, 4-pentadiamine diphosphate, is used for the treatment of chloroquine-sensitive malaria falciparum malaria, vivax malaria and other malaria.It can also be used for the treatment of parenteral amoebiasis, as well as anti-rheumatic effect.
Name | CAS | molecular formula | Density | |
Chloroquinediphosphate | 50-63-5 | C18H32ClN3O8P2 | 1.16 |